ARCHIVES

CMS To Begin National Coverage Analysis Of Provenge

This article is from The Cancer Letter archive.

Vol. 36 No. 25 | July 2, 2010

Download PDF Visit The Full Archive

Related Articles

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

May 9, 2003

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

Operative Laparoscopy Safe For Endometrial Cancer

April 30, 2004

Cancer Control Awards $1 .5 Million Grant For 3-Year Study By College Of Radiology

April 26, 1974

Avon to Support Community Programs

January 7, 1994